CLINICAL_TRIALS
trial_result
· 2013-11-11
Clinical Trial Update: Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia [Phase 4]
Summary
A Phase 4 trial evaluated three dosing regimens of aripiprazole in adults with acute schizophrenia and has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED